TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/7/25 20:04 | 1/3/25 | RNAC | Cartesian Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MD | DO | P,CEO | S.m | -290 | 16.78 | 0 | -17 | -8 | 204 | D | ||||||||||||||
9/26/23 18:01 | 9/25/23 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MA | DO | P,CEO | S | -3 | 1.06 | 0 | -3 | 0 | 783 | D | ||||||||||||||
1/6/23 17:16 | 1/4/23 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MA | DO | P,CEO | S.m | -47 | 1.13 | 0 | -41 | -5 | 786 | D | ||||||||||||||
12/7/22 16:17 | 12/5/22 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MA | DO | P,CEO | S | -6 | 1.33 | 0 | -5 | -1 | 544 | D | ||||||||||||||
9/30/22 19:37 | 9/28/22 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MA | DO | P,CEO | S | -4 | 1.66 | 0 | -3 | 0 | 538 | D | ||||||||||||||
9/6/22 20:37 | 9/2/22 | SELB | Selecta Biosciences Inc | DE | Health | Drug | Pharmaceutical Preparations | Brunn Carsten | MA | DO | P,CEO | S.d | -9 | 1.85 | 0 | -5 | -1 | 541 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |